⌘K

Login Start Free

Home/Filings/4/0001610717-25-000012

4//SEC Filing

Cislini Jeff 4

Accession 0001610717-25-000012

CIK 0001628171other

View on SEC.gov Company Profile

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 5:30 PM ET

Size

4.6 KB

Accession

0001610717-25-000012

Insider Transaction Report

Form 4

Period: 2025-01-21

Revolution Medicines, Inc.RVMD

General Counsel

Transactions

Sale
Common Stock
2025-01-21$40.50/sh−2,406$97,443→ 39,222 total

Footnotes (2)

[F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024.
[F2]Includes 36,204 restricted stock units.

Documents

1 file

4
form4.xmlPrimary

Issuer

Revolution Medicines, Inc.

CIK 0001628171

Entity typeother

Related Parties

1

filerCIK 0001969082

Filing Metadata

Form type: 4
Filed: Jan 21, 7:00 PM ET
Accepted: Jan 22, 5:30 PM ET
Size: 4.6 KB

View on SEC.gov